antibiotic

This page covers all antibiotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting unknown, Not specified, Dihydropteroate synthase, Dihydrofolate reductase.

Targets

unknown · Not specified · Dihydropteroate synthase, Dihydrofolate reductase · Bacterial cell wall enzymes or proteins · RNA polymerase beta subunit · PBPs (Penicillin-binding proteins) · Bacterial cell membrane · RNA polymerase · 1-deoxy-D-xylulose-5-phosphate reductoisomerase, 50S ribosomal subunit · DXR, 50S ribosomal subunit

Marketed (3)

• Atm-Avi · Pfizer · Infectious Disease
  ATM-AVI's mechanism of action is not specified on Wikipedia.
• Various · Pfizer · Immunology
• Sequential therapy 10 days · Incheon St.Mary's Hospital · Infectious Diseases
  Sequential therapy is a treatment approach that involves a combination of antibiotics to treat bacterial infections.

Phase 3 pipeline (10)

• Sulfadoxine pyrimethamine (SP) · Menzies School of Health Research · Infectious Diseases
  Sulfadoxine pyrimethamine (SP) is a combination antibiotic that works by inhibiting the growth of bacteria by interfering with their ability to synthesize folic acid.
• Susceptibility-Guided Quadruple Therapy · Sixth Affiliated Hospital, Sun Yat-sen University · Gastroenterology
  Susceptibility-Guided Quadruple Therapy is a treatment approach that combines antibiotics to effectively target and eliminate Helicobacter pylori bacteria.
• Intravitreal Antibiotics · National Eye Institute (NEI) · Ophthalmology
  Intravitreal antibiotics are antimicrobial agents injected directly into the vitreous cavity of the eye to treat or prevent bacterial infections within the eye.
• Standard of Care Antibiotics · Rebiotix Inc. · Infectious Diseases
  Standard of care antibiotics work by inhibiting bacterial cell wall synthesis or interfering with protein synthesis.
• Lysobact Complete Sprey · Bosnalijek D.D · Infectious Diseases
  Lysobact Complete Sprey is a broad-spectrum antibiotic spray.
• antibiotic of Investigator's choice · Achaogen, Inc. · Infectious Disease
  This antibiotic inhibits bacterial protein synthesis by binding to the bacterial ribosome.
• guideline-guided antibiotic therapy · Capital Medical University · Infectious Diseases
  Guideline-guided antibiotic therapy involves the use of antibiotics based on clinical guidelines to treat bacterial infections.
• double-blind rifaximin · Bausch Health Americas, Inc. · Gastroenterology
  Rifaximin works by inhibiting bacterial RNA synthesis.
• Short antibiotic treatment · Assistance Publique - Hôpitaux de Paris · Infectious diseases
  This drug targets bacterial cell wall synthesis to inhibit bacterial growth.
• triple antibiotic paste (TAP) · King Abdulaziz University · Dermatology
  Triple antibiotic paste (TAP) works by combining the antibacterial properties of three antibiotics to treat bacterial infections.

Phase 2 pipeline (5)

• BV100 plus Polymyxin B · BioVersys AG · Infectious Disease
  BV100 targets the bacterial cell membrane, disrupting its integrity and leading to cell death, in combination with Polymyxin B, an antibiotic that targets the bacterial cell wall.
• Low Dose Rifaximin DER · Bausch Health Americas, Inc. · Infectious Disease
  Inhibits bacterial RNA synthesis
• Fosmidomycin and clindamycin · Zentopharm GmbH · Infectious Diseases
  Fosmidomycin inhibits the enzyme 1-deoxy-D-xylulose-5-phosphate reductoisomerase, which is involved in the biosynthesis of isoprenoids, while clindamycin is a lincosamide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit.
• Fosmidomycin and Clindamycin co-administration · Jomaa Pharma GmbH · Infectious Diseases
  Fosmidomycin inhibits the enzyme 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR), which is involved in the biosynthesis of isoprenoids, while clindamycin inhibits protein synthesis by binding to the 50S ribosomal subunit.
• DFA-02 Antibiotic Gel · Dr. Reddy's Laboratories Limited · Dermatology
  DFA-02 Antibiotic Gel works by targeting and killing bacteria on the skin.